Internet Computer ICP

Bitcoin Cash BCH

Litecoin LTC

TMS Co. Ltd.

4891

Current price

207 JPY -6.04 JPY (-2.82%)

Last closed 217 JPY

Company –

ISIN unknown

Sector Healthcare

Industry Biotechnology

Exchange Tokyo Stock Exchange

Capitalization 8 004 954 228 JPY

Yield for 12 month -20.99 %

10Y

15Y

4891

21.11.2021 - 28.11.2021

TMS Co., Ltd. engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities. The company is developing TMS-007, a stachybotrys microspora triprenyl phenol (SMTP) congener with prothrombolytic and anti-inflammatory/antioxidative activities, which has completed Phase 2a clinical trials for acute ischemic stroke treatment; and TMS-008, an SMTP congener with anti-inflammatory/antioxidative activities under nonclinical development for inflammatory complications, such as acute kidney injury and cancer cachexia. It is also developing TMS-009, a product candidate in preclinical development. The company has a collaboration with Hokkaido University and Kanazawa University to evaluate the potential of the drug candidate compounds as novel drugs, as well as a joint research agreement with Teikyo University to identify biomarkers for renal function and a strategic alliance with Ji Xing Pharmaceuticals Limited. TMS Co., Ltd. was incorporated in 2005 and is headquartered in Fuchu, Japan. Address: 1-9, Fuchu-shi, Fuchu, Japan, 183-0055

Check your investment idea

Find the best to beat the market

TSLA Tesla Motors

AAPL Apple

MSFT Microsoft

Activate

View

Activate

View

Analytics

WallStreet Target Price

118 347.01 JPY

P/E ratio

–

Dividend Yield

–

Revenue
Profit

Current Year

–

Last Year

–

Current Quarter

–

Last Quarter

–

Current Year

-7 038 221 JPY

Last Year

-6 679 599 JPY

Current Quarter

-237 005 JPY

Last Quarter

-3 282 105 JPY

1 year

3 years

5 years

10 years

21.11.2021 - 28.11.2021

EBITDA -1 057 241 023 JPY

Operating Margin TTM –

PE Ratio –

Return On Assets TTM -20.12 %

PEG Ratio –

Return On Equity TTM -34.42 %

Wall Street Target Price 118 347.01 JPY

Revenue TTM –

Book Value 75.03 JPY

Revenue Per Share TTM

Dividend Share –

Quarterly Revenue Growth YOY –

Dividend Yield –

Gross Profit TTM –

Earnings per share -28.87 JPY

Diluted Eps TTM -28.87 JPY

Most Recent Quarter III 2024

Quarterly Earnings Growth YOY –

Profit Margin –

Dividend growth over 5 years

–

Continuous growth

–

Payout Ratio 5 years average

–

1 year

3 years

5 years

10 years

21.11.2021 - 28.11.2021

Forward Annual Dividend Rate –

Ex Dividend Date –

Forward Annual Dividend Yield –

Last Split Factor –

Payout Ratio –

Last Split Date –

Dividend Date –

1 year

3 years

5 years

10 years

21.11.2021 - 28.11.2021

Trailing PE –

Forward PE –

Enterprise Value Revenue 4.1148

Price Sales TTM –

Enterprise Value EBITDA -10.271

Price Book MRQ 2.6317

Financials 4891

1 year

3 years

5 years

10 years

15 years

Track key metrics for each stock in one place without the hassle

Get Premium

Results	2019	Dynamics

* The data for this period has not yet been published

138.74 JPY 371.65 JPY

50 Day MA 197.41 JPY

Shares Short Prior Month –

200 Day MA 239.22 JPY

Short Ratio –

Shares Short –

Short Percent –

	All time	January, 22	February, 22	March, 22	April, 22	May, 22	June, 22
Companies with BMS 90+	+10.12%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%
Companies with BMS 60-	+10.12%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%

Similar to

TMS Co. Ltd.